The determination of the seroprevalence of vaccine-preventable diseases is critical in monitoring the efficacy of vaccination programmes and to assess the gaps in population …
E Palazzotto, F Bonura, C Calà… - Journal of Medical …, 2023 - microbiologyresearch.org
Introduction. Serological screening and seroprevalence data for TORCH infections represent a key instrument to estimate immunity and vaccination levels and exposure rates …
A Bukasa, H Campbell, K Brown, H Bedford… - …, 2018 - eurosurveillance.org
Rubella vaccination has been included in the United Kingdom's (UK) routine childhood schedule for nearly 30 years. The UK achieved World Health Organization (WHO) …
Objective Nonimmune pregnant women are at risk of developing congenital rubella syndrome and measles complications. We aimed to identify pregnant women susceptible to …
R Barlinn, K Vainio, HH Samdal… - Journal of medical …, 2014 - Wiley Online Library
Infections caused by cytomegalovirus (CMV), parvovirus B19 (B19), and rubella can lead to serious complications in pregnant women. The aim of this study was to determine the …
Long term control of rubella and congenital rubella syndrome relies on high population-level immunity against rubella, particularly among women of childbearing age. In Canada, all …
A Vilajeliu, AL García-Basteiro, S Valencia, S Barreales… - Vaccine, 2015 - Elsevier
Background Elimination of congenital rubella syndrome depends not only on effective childhood immunization but also on the identification and immunization of rubella …
SN Crooke, IH Haralambieva, DE Grill… - Vaccine, 2019 - Elsevier
Background Although the administration of the measles-mumps-rubella (MMR) vaccine has been widespread in the United States for decades, gaps in vaccine coverage still persist for …
Background While administration of the measles-mumps-rubella (MMR-II®) vaccine has been effective at preventing rubella infection in the United States, the durability of humoral …